Anemia with Excess Blasts
📧 Sign up to get email alerts when something new happens for Anemia with Excess Blasts.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia [Phase 2]
This Phase 2 trial examines hematopoietic stem cell transplantation for infant leukemia and has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome [Phase 1]
Phase 1 trial of a conditioning regimen including an iodine-131 labeled monoclonal antibody with fludarabine, cyclophosphamide, total-body i…
-
CLINICAL_TRIALS trial_result · 2022-08-01Clinical Trial Update: Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating a combined regimen including iodine-131 monoclonal antibody BC8, fludarabine phosphate, total body irradia…
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine [Phase 3]
Phase 3 trial updating the efficacy and safety of intravenous rigosertib in myelodysplastic syndrome patients with excess blasts who progres…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial updating the use of off-the-shelf expanded cord blood cells to augment cord blood transplant in patients with various…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [Phase 1]
Phase 1 trial evaluating donor peripheral blood stem cell transplantation in combination with pretargeted radioimmunotherapy for patients wi…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports completion of a study evaluating an investigational biological therapy in adults with advanced mye…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies [Phase 2]
Phase 2 trial of Brentuximab Vedotin in CD30-positive non-lymphomatous malignancies has completed and results were posted in 2016. The study…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Tipifarnib in Treating Patients With Myelodysplastic Syndromes [Phase 1]
Phase 1 clinical trial update showing completion of a tipifarnib study in patients with myelodysplastic syndromes and related myeloid disord…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
This entry reports a terminated clinical trial (NCT01463410) evaluating the accuracy of chromosomal aberration and gene mutation markers for…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies [Phase 1]
Phase 1 study evaluating Hum-195/rGel, an anti-CD-33 immunotoxin, in patients with advanced myeloid malignancies including acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia [Phase 1]
Phase 1 trial evaluating flavopiridol and vorinostat in relapsed or refractory acute leukemias and related myeloid disorders has completed e…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia [Phase 1]
Phase 1 study of BMS-214662 in patients with various leukemias and myelodysplastic syndromes has completed enrollment; the document lists th…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy [Phase 1, Phase 2]
This clinical trial update reports on a completed Phase 1/2 study of liposomal daunorubicin combined with SU5416 for hematologic cancers tha…